We have followed the CLARITY Act week by week since spring, when every new deadline turned into the next one. On 15 September the Senate finally voted. The cloture motion to proceed to H.R. 3633 failed 49 to 50, well short of the 60 votes required.
What sank it
The core of the bill, splitting oversight of digital assets between the SEC and the CFTC, was not the problem. The dispute was over ethics language governing officials' crypto holdings. Democrats argued the draft did not effectively cover the president and his family; Republicans pointed to more than 100 revisions they said had been made at Democrats' request. Stablecoin yield, the issue that stalled negotiations in April, remained unresolved in the background.
Two days later, seven Democratic senators who had worked on the text, among them Gallego, Gillibrand and Warner, called the result "a setback, but not the end" and recommitted to a bipartisan deal. Senator Thom Tillis entered a motion to reconsider, which keeps the procedural door open.
The calendar is the real opponent
The Senate's next work period runs from 5 October to 6 November, straight into the midterm campaign. A lame-duck session after the election is the most plausible window, and prediction markets currently price passage this year in the single digits.
What this means for the industry
- Agency action fills the gap. Expect the SEC and CFTC to keep moving through exemptions, no-action relief and rulemaking. Those tools are faster than legislation but can be reversed by the next administration.
- Europe's head start grows. MiCA has applied to stablecoins since mid-2024 and the ECB launched Pontes for tokenised settlement this week. For firms choosing where to build regulated products first, the EU now offers the clearer rulebook.
- Stablecoin yield stays open. Without CLARITY, the question of whether platforms may pass reserve income to users remains governed by the GENIUS Act and agency interpretation.
The bill is not dead. But for 2026, CLARITY has turned from a legislative story into a regulatory one.
